Skip to content

Medical-device intelligence

JBL: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative

FDA product code JBL: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JBL
FDA device name
Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative
Device class
2
Regulation number
864.7360
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 2 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Mar 15, 1979 to Apr 3, 2019.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
G-6-PDH Deficient Control (G-6-PDH CONTROL D), Catalogue Number PD2617 Product Usage: This product is intended for in vitro diagnostic use, in t…Z-1254-2019 · JBLRandox Laboratories Ltd.RecallMay 3, 2019FDA record creation date
G-6-PDH Normal Control (G-6-PDH CONTROL N), Catalogue Number PD2618 Product Usage: This product is intended for in vitro diagnostic use, in the …Z-1255-2019 · JBLRandox Laboratories Ltd.RecallMay 3, 2019FDA record creation date
ASTORIA-PACIFIC SPOTCHECK G6PD KIT 50 HR, MODEL 80-3000-13KK990957 · JBLAstoria-Pacific, Inc.510(k)May 11, 1999FDA decision date
DEHYDROGENOSE, GLUCOSE PHOSPHATEK790211 · JBLSigma Chemical Co.510(k)Mar 15, 1979FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗